Captrust Financial Advisors Genprex, Inc. Transaction History

Captrust Financial Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$2.59 - $3.36 $1,149 - $1,491	-444 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.11 - $4.87 $335 - $525	108 Added 32.14%	444 $1,000
Q1 2021 May 17, 2021	BUY	$3.66 - $7.67 $1,229 - $2,577	336 New	336 $1,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.